Premium Articles

Powering Cancer Drug Discovery and Development Using the Artificial Intelligence and Machine Learning Platform RADR®

Introduction Glioblastomas (GBM) are devastating brain tumors and rank as one of the most aggressive human cancers with a median …

Continue ›››

11 AI-powered Drug Discovery Startups Founded in 2021

The community of AI-driven biotech companies is continuously expanding, adding new players to the drug discovery race. In 2021 several …

Continue ›››

Turbocharging Phenotypic Screening with AI to Target mRNA Biology

While the pharmaceutical world is investigating biologics or mRNA-based therapies, Yochi Slonim, Israeli technology and biotech entrepreneur and public speaker …

Continue ›››

Protein Degraders Take Industry By Storm

Proteins are essential components of living matter — they function as building blocks for cells and tissues, as well as …

Continue ›››

Why Scandinavia is a Life Sciences Hub to Watch

Scandinavian countries are known for their active innovation in the worldwide market, including pharmaceutical and biotech fields. Numerous research institutes, …

Continue ›››

On Quantum Theory, Drug Discovery, and Life Sciences Ecosystem in Spain: Interview with Dr. Enric Gibert

In contrast to molecular mechanics, which describes molecules as essentially “balls and sticks” kind of objects, taking into account only …

Continue ›››

Using End-to-End Wet Lab Automation Combined with Machine Learning to Industrialize Drug Discovery

Arctoris is driven by a relentless pursuit to make drug discovery better. An industry where bringing a single drug to …

Continue ›››

A Market Review of DNA-encoded Libraries Technology in Drug Discovery

(Last updated: October 05, 2022) The interest of pharma organizations in DNA-encoded chemical libraries (DEL) technology has been growing over …

Continue ›››

Identifying High Impact Tissue Sparing E3 Ligases and Their Binders

There are many drug target classes for which unwanted on-target pharmacology limits clinical application. Understanding E3 tissue expression across both …

Continue ›››

QUAISAR Computational Platform for Designing Targeted Protein Degraders

A key step in the targeted protein degradation (TPD) process is the formation of an induced proximity complex, where a …

Continue ›››

Application of AI-driven Xanthos Platform for Designing Protein Degraders

In contrast to the discovery of "traditional drugs" such as small molecule inhibitors and most biologics, the development of protein …

Continue ›››

DNA-encoded Libraries Meet Artificial Intelligence

The concept of deoxyribonucleic acid (DNA)-encoded chemical libraries was invented three decades ago, but only recently it has become a …

Continue ›››